z-logo
open-access-imgOpen Access
Targeting glioblastoma signaling and metabolism with a re-purposed brain-penetrant drug
Author(s) -
Junfeng Bi,
Atif Ali Khan,
Jun Tang,
Aaron M. Armando,
Sihan Wu,
Wei Zhang,
Ryan C. Gimple,
Alex Reed,
Hui Jing,
Tomoyuki Koga,
Ivy Tsz-Lo Wong,
Yuchao Gu,
Shunichiro Miki,
Huijun Yang,
Briana C. Prager,
Ellis J. Curtis,
Derek A. Wainwright,
Frank B. Furnari,
Jeremy N. Rich,
Timothy F. Cloughesy,
Harley I. Kornblum,
Oswald Quehenberger,
Andrey Rzhetsky,
Benjamin F. Cravatt,
Paul S. Mischel
Publication year - 2021
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2021.109957
Subject(s) - temozolomide , fluoxetine , antidepressant , pharmacology , ceramide , drug repositioning , medicine , drug , cancer research , oncology , biology , apoptosis , glioblastoma , serotonin , receptor , hippocampus , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom